Preparation and application of attenuated lipoid A

A technology of gene fragments and recombinant Escherichia coli, which is applied in the field of genetic engineering, can solve problems such as structural damage and complex production processes, and achieve the effects of reducing production processes, easy extraction and preparation, and broadening the scope of clinical applications

Inactive Publication Date: 2018-08-14
JIANGNAN UNIV
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, MPL also has deficiencies in industrial production and clinical application. For example, the production of MPL Salmonella belongs to conditional pathogenic bacteria. There a...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and application of attenuated lipoid A
  • Preparation and application of attenuated lipoid A
  • Preparation and application of attenuated lipoid A

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The construction of embodiment 1 genetically engineered bacteria

[0030] Find out the lpxD1 and lpxD2 gene sequences. Select restriction sites according to the nucleotide sequences of lpxD1, lpxD2 and pUC plasmids. Design primers, carry out PCR, and recover lpxD1 and lpxD2 gene expression fragments. The expression gene fragment and the pUC18 plasmid were digested respectively. Ligate the expressed gene fragment and pUC18 plasmid after enzyme digestion. The ligated plasmid was introduced into E.coli RL25 by chemical transformation (for the construction method of E.coli RL25, please refer to the literature: Bartling C M, Raetz CR. Crystal structure and acyl chain selectivity of Escherichia coli LpxD, the N-acyltransferase of lipid Abiosynthesis .Biochemistry, 2009,48(36):8672-8683), W3110 and HW002 (the construction method of E.coli HW002 can be found in literature: Wang X, Zhang C, Shi F, HuX.Purification and characterization of lipopolysaccharides.SubcellularBiochem...

Embodiment 2

[0031] Example 2 Structural Analysis of Genetically Engineered Bacteria E.coli RL25 / pUC-lpxD1 and E.coli RL25 / pUC-lpxD2 Lipid A

[0032] 1. Extraction method of lipid A

[0033] Lipid A was extracted using chloroform / methanol / H 2 O solution mixed phase extraction. The overnight cultured bacterial solution was divided into initial OD 600 =0.02 transferred to 200mL LB liquid medium, cultivated at 37°C to the late logarithmic phase of the bacteria, centrifuged at 4000rpm for 30min to collect the bacteria, ddH 2 After washing the cells once, use Bligh-Dyer one-phase system (chloroform / methanol / water solution, 1:2:0.8, v / v / v) to suspend the cells in 76mL, magnetically stir for 1h, and centrifuge at 2000rpm for 30min to separate the phases. Wash the cell fragments 2-3 times with the system; add 27mL of 12.5mM sodium acetate (PH4.5) solution, ultrasonically shake for 2min, and cleavage the sugar chains in a water bath at 100°C for 30min. After cooling to room temperature, add 30m...

Embodiment 3

[0045] Example 3 Analysis of changes in the self-agglutination ability of genetically engineered bacteria E.coli RL25 / pUC-lpxD1 and E.coli RL25 / pUC-lpxD2

[0046] The overnight cultured bacterial solution was divided into initial OD 600 =0.02 transferred to 50mL LB liquid medium, 37 ° C, 200r / min culture to OD 600 =2; cells were collected by centrifugation, washed once with pH 7.4 phosphate buffer (PBS) and resuspended to control OD 600 = 2; take 10mL into a 15mL centrifuge tube, put it in a 4°C environment, and after 24 hours, take the top bacterial solution to measure the OD, and calculate the OD of the bacterial cell by the calculation method (2-OD600 above the bacterial solution) / 2 self-aggregating ability.

[0047] The result is as Figure 4 As shown, the comparison shows that the autoagglutination ability of E.coli RL25 / pUC-lpxD1 and E.coli RL25 / pUC-lpxD2 is about 2 times higher than that of E.coli RL25.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation and application of attenuated lipoid A, and belongs to the technical field of gene engineering. According to the attenuated lipoid A disclosed by the invention, alpxD1 gene fragment is expressed in non-pathogenic Escherichia coli or the lpxD2 gene fragment carries out molecular modification on the attenuated lipoid A to obtain the attenuated lipoid A with a changed fatty acid chain structure; however, the toxicity of the recombinant Escherichia coli for expressing the lpxD1 gene fragment or the lpxD2 gene fragment to cells is reduced. The invention provides a novel method and idea for preparing a vaccine adjuvant.

Description

technical field [0001] The invention relates to the preparation and application of attenuated lipid A, belonging to the technical field of genetic engineering. Background technique [0002] Lipopolysaccharide (LPS), commonly known as endotoxin, is located on the outside of the outer membrane of Gram-negative bacteria and is the main component of this site. It is composed of lipid A, core polysaccharide and O antigen. Lipid A is the active center of lipopolysaccharide and the main structure that causes immune response. LPS can stimulate the host's non-specific immunity. LPS binding protein (LBP) transports LPS to the cell surface, and with the help of CD14 and MD-2, it is recognized by the receptor Toll like receptor4 (TLR4) on the cell surface, followed by a series of signal transduction, which eventually leads to a series of inflammation factor release. Among them, there are mainly two signaling pathways, Mal-MyD88 and TRAM-TRIF, which can produce different biological cy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07H11/04C12P19/26C12N15/70C12N1/21A61K39/39A61P37/04C12R1/19
CPCA61K39/39A61K2039/55572A61K2039/55594A61P37/04C07H11/04C12N15/70C12P19/26
Inventor 李颜颜王小元李烨云建贾向印
Owner JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products